Get Ready to Laugh and Learn: 89bio Drops More Knowledge on Pegozafermin for NASH at AASLD 2023!
Welcome to my quirky blog post! Let’s Talk Liver Health: A Recap of 89bio’s Latest Announcement Hey there, fellow health enthusiasts! Today, I want to dive into the latest news from 89bio, Inc. about their ENLIVEN Phase 2b Trial. The recent update from San Francisco revealed some fascinating insights into liver inflammation and fibrosis in…